Linagliptin 2.5 mg + Metformin 850 mg Tablet (Linaglite-M 2.5/850)
Linagliptin 2.5 mg + Metformin 850 mg
| Composition | Linagliptin 2.5 mg + Metformin 850 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 10 (Blister) |
| MRP | ₹ 1880 |
| Therapy | Cardiac + Diabetic — DPP-4 inhibitor + biguanide (FDC) |
| Storage | Store below 25°C. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Linaglite-M 2.5/850 (linagliptin 2.5 mg + metformin 850 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
About Linaglite-M 2.5/850 Tablet
Linaglite-M 2.5/850 Tablet contains Linagliptin 2.5 mg and Metformin 850 mg in a fixed-dose combination. Twice-daily dosing delivers Linagliptin 5 mg total and Metformin 1700 mg total — providing intermediate-strength biguanide between the 500 mg and 1000 mg combinations.
Indicated for type-2 diabetes inadequately controlled on metformin monotherapy or when intermediate biguanide dosing is preferred.
Camrut Healthcare manufactures Linaglite-M 2.5/850 under WHO-GMP conditions for PCD pharma franchise across India.
Linaglite-M 2.5/850 का उपयोग (हिंदी में): टाइप 2 डायबिटीज़ (शुगर) की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।
Indications
- Type-2 DM uncontrolled on metformin
- Patients needing intermediate metformin strength
- Step-up from Linaglite-M 2.5/500
Mechanism of Action
Linagliptin inhibits DPP-4, prolonging incretin activity. Metformin activates AMPK, reducing hepatic gluconeogenesis and improving insulin sensitivity. Complementary mechanisms address both insulin secretion and insulin resistance.
Dosage & Administration
['Adults: 1 tablet twice daily with meals', 'Swallow whole', 'Monitor renal function and HbA1c', 'Use under physician supervision']
Side Effects
['GI upset', 'Metallic taste', 'Nasopharyngitis', 'Vitamin B12 deficiency (chronic)']
Contraindications & Precautions
['Type-1 diabetes', 'Diabetic ketoacidosis', 'eGFR < 30 mL/min/1.73 m²', 'Severe hepatic impairment', 'Pregnancy and breastfeeding']
Storage
Store below 25°C.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the cardiac-diabetic products franchise product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Linaglite-M 2.5/850 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products